Stacey A. Rizza, M.D.
Stacey A. Rizza, M.D. is the Medical Director For Global Commercial Solutions at Mayo Clinic International. Her experience in international practice and academic initiatives provides a global perspective for healthcare collaborations. In August 2023, Dr. Rizza was also appointed Medical Director for the Office of Staff Services, which offers a personalized, confidential referral and resource system and financial planning services to voting and consulting staff. She also serves as an infectious disease physician at Mayo Clinic in Rochester, Minnesota.
Dr. Rizza has been involved in laboratory-based research, clinical research, and educational initiatives while maintaining a busy clinical practice. She is a Professor of Medicine and previous Chair of the Mayo HIV Clinic. Dr. Rizza served as the Associate Dean of the Mayo Clinic School of Health Sciences and previously served as President of the Mayo Clinic Staff and as Associate Director for Diversity and Inclusion, Mayo Clinic Transplant Center.
Dr. Rizza has held NIH grants and received a patent for her work on HIV and HCV mediated apoptosis. She was the Chair of the National Comprehensive Cancer Network (NCCN)/African Collaboration for the HIV and Cancer Treatment Guidelines Committee and a member of workgroups in The International Network for Strategic Initiatives in Global HIV Trials (INSIGHT). She has served on committees and held roles with the Infectious Disease Society of America, the World Health Organization (WHO), and the Center for Disease Control (CDC).
Dr. Rizza holds a bachelor’s degree in Biochemistry from Haverford College and a medical degree from the Mayo Clinic Alix School of Medicine. She did an internal medicine residency and infectious disease fellowship at the Mayo Clinic School of Graduate Medical Education, followed by a post-doctoral fellowship in HIV and HCV Immunology at the University of California, San Francisco. She is based in Rochester.
